十多家上市药企被立案,医药是财务造假重灾区吗?

财经大健康
31 Dec 2024

虚增营收、利润、成本,是常见的财务造假行为文 |凌馨编| 孙爱民诺辉健康杭州办公室 摄/孙爱民2024年12月31日清晨,诺辉健康(06606.HK)发布公告:董事会宣布朱叶青因个人健康原因已于2024年12月30日辞任董事会主席及首席执行官。公告提到,董事会认为朱叶青的管理风格及理念与董事会其他成员有重大差异,且允许朱叶青继续参与本公司的管理并不符合公司及其股东的整体最佳利益,决议召开股东特别...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10